General Announcement::Press Release

Issuer & Securities

Issuer/ Manager
BIOCON BIOLOGICS GLOBAL PLC
Securities
BIOCONBIO US$800M6.67%N291009A - US090978AA56 - RJUB
BIOCONBIO US$800M6.67%N291009R - USG11185AA61 - KSEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
07-Apr-2026 18:41:26
Status
New
Announcement Sub Title
Press Release
Announcement Reference
SG260407OTHRO6FD
Submitted By (Co./ Ind. Name)
Biocon Biologics Limited / Akhilesh Nand
Designation
Company Secretary
Effective Date and Time of the event
07/04/2026 16:00:00
Description (Please provide a detailed description of the event in the box below)
Biocon Announces U.S. Commercial Launch of Bosaya and Aukelso, Denosumab Biosimilars

Attachments

BBL_SGX_Deno_US Launch_07042026.pdf
Total size =426K